| Lactose (India) Ltd | 121 Cr. | 96.0 | 137/84.3 | 25.0 | 49.6 | 0.00 % | 12.9 % | 9.69 % | 10.0 |
| MPS Pharmaa Ltd | 3.15 Cr. | 1.65 | 3.69/1.60 | | 0.33 | 0.00 % | 9.79 % | 59.0 % | 10.0 |
| Gujarat Themis Biosyn Ltd | 3,313 Cr. | 304 | 479/208 | 69.4 | 24.3 | 0.21 % | 27.3 % | 21.7 % | 1.00 |
| Gujarat Terce Laboratories Ltd | 31.2 Cr. | 40.0 | 76.9/37.2 | | 10.1 | 0.00 % | 41.4 % | 14.6 % | 10.0 |
| Gujarat Inject (Kerala) Ltd | 94.0 Cr. | 64.2 | 64.7/17.0 | 376 | 6.93 | 0.00 % | 13.5 % | 11.0 % | 10.0 |
| Godavari Drugs Ltd | 58.4 Cr. | 77.6 | 115/69.7 | 16.7 | 60.3 | 0.00 % | 10.1 % | 10.6 % | 10.0 |
| Glenmark Life Sciences Ltd | 60,192 Cr. | 2,133 | 2,286/1,275 | 22.3 | 340 | 0.12 % | 19.4 % | 15.8 % | 1.00 |
| Gennex Laboratories Ltd | 270 Cr. | 11.1 | 17.2/10.8 | 15.4 | 8.79 | 0.00 % | 13.0 % | 10.2 % | 1.00 |
| Ganga Pharmaceuticals Ltd | 7.09 Cr. | 12.0 | 14.8/9.25 | 88.6 | 14.0 | 0.00 % | 3.18 % | 1.13 % | 10.0 |
| Fredun Pharmaceuticals Ltd | 879 Cr. | 1,639 | 1,999/635 | 25.9 | 294 | 0.04 % | 18.9 % | 15.8 % | 10.0 |
| Fervent Synergies Ltd | 89.1 Cr. | 17.8 | 29.8/17.0 | 25.8 | 10.8 | 0.00 % | 7.47 % | 7.47 % | 10.0 |
| Fermenta Biotech Ltd | 980 Cr. | 333 | 399/219 | 11.1 | 133 | 0.75 % | 23.0 % | 24.9 % | 5.00 |
| Fabino Enterprises Ltd | 2.75 Cr. | 13.1 | 39.0/13.0 | | 19.2 | 0.00 % | 7.16 % | 3.08 % | 10.0 |
| Evoq Remedies Ltd | 8.14 Cr. | 3.27 | 6.11/2.11 | 4.63 | 17.9 | 0.00 % | 0.35 % | 0.26 % | 10.0 |
| Everest Organics Ltd | 345 Cr. | 355 | 536/211 | 59.1 | 0.00 | 0.00 % | 1.76 % | 2.23 % | 10.0 |
| Entero Healthcare Solutions Ltd | 4,438 Cr. | 1,020 | 1,511/944 | 38.1 | 406 | 0.00 % | 8.71 % | 5.63 % | 10.0 |
| Murae Organisor Ltd | 47.0 Cr. | 0.23 | 1.12/0.20 | 3.12 | 1.02 | 0.00 % | 4.20 % | 5.69 % | 1.00 |
| Dipna Pharmachem Ltd | 23.7 Cr. | 9.02 | 26.3/9.00 | 11.6 | 24.5 | 0.00 % | 6.64 % | 2.55 % | 10.0 |
| Decipher Labs Ltd | 7.56 Cr. | 7.48 | 13.0/7.21 | | 19.0 | 0.00 % | 4.67 % | 1.16 % | 10.0 |
| Coral Laboratories Ltd | 157 Cr. | 440 | 797/415 | 11.0 | 596 | 0.34 % | 17.4 % | 13.1 % | 10.0 |
| Concord Drugs Ltd | 77.0 Cr. | 77.0 | 92.5/26.1 | 145 | 34.4 | 0.00 % | 4.73 % | 0.88 % | 10.0 |
| Concord Biotech Ltd | 12,868 Cr. | 1,230 | 2,150/1,057 | 40.5 | 174 | 0.87 % | 28.4 % | 21.4 % | 1.00 |
| Colinz Laboratories Ltd | 5.96 Cr. | 47.3 | 88.7/36.1 | 12.2 | 39.2 | 0.00 % | 6.72 % | 5.43 % | 10.0 |
| Cian Healthcare Ltd | 12.5 Cr. | 5.01 | 7.66/2.99 | | 13.0 | 0.00 % | 10.6 % | 30.3 % | 10.0 |
| Chemo Pharma Laboratories Ltd | 13.7 Cr. | 91.0 | 153/86.0 | | 9.60 | 0.00 % | 5.17 % | 3.47 % | 10.0 |
| Checkpoint Trends Ltd | 36.0 Cr. | 65.9 | 144/12.2 | 17.5 | 3.60 | 0.00 % | 16.5 % | 9.17 % | 10.0 |
| Chandra Bhagat Pharma Ltd | 30.2 Cr. | 40.0 | 69.0/33.0 | 48.7 | 40.3 | 0.00 % | 6.00 % | 2.41 % | 10.0 |
| Brawn Biotech Ltd | 6.49 Cr. | 21.6 | 24.4/15.5 | | 12.3 | 0.00 % | 42.5 % | 41.3 % | 10.0 |
| Blue Jet Healthcare Ltd | 6,939 Cr. | 400 | 1,028/353 | 23.6 | 72.4 | 0.30 % | 39.8 % | 30.2 % | 2.00 |
| Bharat Immunological & Biological Corporation Ltd | 78.1 Cr. | 18.1 | 28.8/16.6 | | 18.2 | 0.00 % | 9.27 % | 17.7 % | 10.0 |
| Beryl Drugs Ltd | 10.6 Cr. | 21.0 | 30.0/17.4 | 1,065 | 18.6 | 0.00 % | 10.2 % | 6.30 % | 10.0 |
| Mankind Pharma Ltd | 92,388 Cr. | 2,238 | 2,727/2,012 | 52.3 | 376 | 0.04 % | 15.0 % | 13.9 % | 1.00 |
| BDH Industries Ltd | 239 Cr. | 415 | 524/241 | 22.9 | 123 | 1.09 % | 17.8 % | 14.2 % | 10.0 |
| Bacil Pharma Ltd | 68.2 Cr. | 47.5 | 51.5/26.7 | 92.2 | 18.4 | 0.00 % | 0.97 % | 0.98 % | 10.0 |
| Aurobindo Pharma Ltd | 70,759 Cr. | 1,218 | 1,279/994 | 20.0 | 603 | 0.33 % | 14.2 % | 11.1 % | 1.00 |
| Auro Laboratories Ltd | 186 Cr. | 299 | 317/159 | 63.2 | 69.9 | 0.00 % | 3.85 % | 4.33 % | 10.0 |
| Anuh Pharma Ltd | 771 Cr. | 76.9 | 115/68.0 | 18.4 | 32.6 | 1.95 % | 17.2 % | 13.4 % | 5.00 |
| ANG Lifesciences India Ltd | 30.9 Cr. | 23.6 | 39.7/21.0 | | 50.0 | 0.00 % | 3.54 % | 13.8 % | 10.0 |
| Acutaas Chemicals Ltd | 17,724 Cr. | 2,165 | 2,200/930 | 61.7 | 173 | 0.07 % | 19.9 % | 16.0 % | 5.00 |
| Amerise Biosciences Ltd | 4.55 Cr. | 0.69 | 1.06/0.51 | 65.1 | 0.81 | 0.00 % | 0.19 % | 0.19 % | 1.00 |
| Ambalal Sarabhai Enterprises Ltd | 204 Cr. | 26.6 | 42.0/23.1 | 11.5 | 19.2 | 0.00 % | 9.12 % | 6.25 % | 10.0 |
| Adline Chem Lab Ltd | 8.20 Cr. | 14.0 | 19.1/7.60 | 273 | 2.75 | 0.00 % | % | % | 10.0 |
| Achyut Healthcare Ltd | 123 Cr. | 5.22 | 6.80/2.82 | 286 | 1.34 | 0.00 % | 2.26 % | 1.77 % | 1.00 |
| Abbott India Ltd | 55,488 Cr. | 26,112 | 37,000/26,006 | 36.4 | 1,888 | 1.81 % | 46.2 % | 35.7 % | 10.0 |
| Aarti Pharmalabs Ltd | 6,524 Cr. | 720 | 972/557 | 30.2 | 226 | 0.69 % | 17.4 % | 14.5 % | 5.00 |
| Aarey Drugs & Pharmaceuticals Ltd | 220 Cr. | 77.4 | 100/31.3 | 64.0 | 52.5 | 0.00 % | 6.38 % | 2.96 % | 10.0 |
| Zota Health Care Ltd | 4,108 Cr. | 1,216 | 1,740/752 | | 93.5 | 0.08 % | 17.0 % | 36.0 % | 10.0 |
| Wockhardt Ltd | 22,148 Cr. | 1,363 | 1,870/1,110 | 204 | 281 | 0.00 % | 3.75 % | 1.22 % | 5.00 |
| Wanbury Ltd | 926 Cr. | 265 | 330/154 | 21.6 | 18.1 | 0.00 % | 36.7 % | 76.5 % | 10.0 |
| Vivimed Labs Ltd | 63.0 Cr. | 7.60 | 29.4/6.65 | | 5.79 | 0.00 % | 8.10 % | % | 2.00 |
| Venus Remedies Ltd | 905 Cr. | 677 | 873/278 | 11.9 | 445 | 0.00 % | 11.1 % | 7.16 % | 10.0 |
| Unichem Laboratories Ltd | 2,471 Cr. | 351 | 728/345 | 23.5 | 346 | 0.00 % | 6.24 % | 5.59 % | 2.00 |
| TTK Healthcare Ltd | 1,298 Cr. | 918 | 1,402/905 | 18.6 | 768 | 1.09 % | 9.26 % | 6.89 % | 10.0 |
| Torrent Pharmaceuticals Ltd | 1,48,346 Cr. | 4,383 | 4,470/2,886 | 64.4 | 250 | 0.73 % | 27.0 % | 26.5 % | 5.00 |
| Themis Medicare Ltd | 798 Cr. | 86.6 | 179/75.2 | | 41.3 | 0.58 % | 10.4 % | 7.65 % | 1.00 |
| Syncom Formulations (India) Ltd | 1,198 Cr. | 12.8 | 23.5/11.5 | 17.4 | 4.00 | 0.00 % | 18.6 % | 15.5 % | 1.00 |
| Cohance Lifesciences Ltd | 11,607 Cr. | 303 | 1,250/303 | 38.6 | 99.0 | 0.00 % | 14.9 % | 12.7 % | 1.00 |
| Suven Life Sciences Ltd | 3,386 Cr. | 146 | 303/102 | | 12.4 | 0.00 % | 87.0 % | 87.2 % | 1.00 |
| Sun Pharmaceuticals Industries Ltd | 4,25,570 Cr. | 1,774 | 1,851/1,547 | 35.1 | 324 | 0.91 % | 20.2 % | 16.9 % | 1.00 |
| Solara Active Pharma Sciences Ltd | 2,048 Cr. | 460 | 734/440 | | 347 | 0.00 % | 6.01 % | 0.05 % | 10.0 |
| SMS Pharmaceuticals Ltd | 3,605 Cr. | 385 | 394/175 | 41.3 | 81.2 | 0.10 % | 12.2 % | 11.0 % | 1.00 |
| SMS Lifesciences India Ltd | 357 Cr. | 1,197 | 1,680/956 | 20.6 | 650 | 0.13 % | 11.8 % | 10.8 % | 10.0 |
| Shilpa Medicare Ltd | 6,465 Cr. | 331 | 502/260 | 36.6 | 125 | 0.15 % | 7.82 % | 4.21 % | 1.00 |
| Sequent Scientific Ltd | 8,768 Cr. | 201 | 260/111 | 203 | 32.2 | 0.00 % | 8.47 % | 3.21 % | 2.00 |
| Sanofi India Ltd | 9,246 Cr. | 4,015 | 6,718/3,951 | 26.7 | 326 | 2.91 % | 57.5 % | 43.0 % | 10.0 |
| RPG Life Sciences Ltd | 3,093 Cr. | 1,870 | 2,725/1,772 | 29.4 | 335 | 1.07 % | 32.8 % | 25.5 % | 8.00 |
| Procter & Gamble Health Ltd | 8,254 Cr. | 4,973 | 6,739/4,904 | 28.1 | 373 | 2.52 % | 47.8 % | 36.4 % | 10.0 |
| Pharmaids Pharmaceuticals Ltd | 112 Cr. | 31.9 | 76.0/30.0 | | 14.7 | 0.00 % | 17.4 % | 16.3 % | 10.0 |
| Pfizer Ltd | 23,353 Cr. | 5,105 | 5,993/3,701 | 30.7 | 841 | 0.69 % | 21.6 % | 16.4 % | 10.0 |
| Par Drugs & Chemicals Ltd | 116 Cr. | 94.0 | 122/81.0 | 8.30 | 86.5 | 0.00 % | 18.4 % | 13.6 % | 10.0 |
| Panacea Biotec Ltd | 2,046 Cr. | 334 | 582/281 | | 135 | 0.00 % | 4.57 % | 4.92 % | 1.00 |
| Ortin Laboratories Ltd | 16.4 Cr. | 20.1 | 26.4/16.2 | | 3.47 | 0.00 % | 60.2 % | 118 % | 10.0 |
| Orchid Pharma Ltd | 3,150 Cr. | 621 | 1,005/604 | 121 | 251 | 0.00 % | 8.07 % | 8.21 % | 10.0 |
| Neuland Laboratories Ltd | 16,445 Cr. | 12,817 | 19,748/10,060 | 91.8 | 1,263 | 0.09 % | 18.7 % | 14.8 % | 10.0 |
| Nectar Lifescience Ltd | 237 Cr. | 12.2 | 30.0/12.0 | | 32.0 | 0.00 % | 5.36 % | 11.2 % | 1.00 |
| Natco Pharma Ltd | 17,658 Cr. | 986 | 1,060/660 | 11.4 | 483 | 0.62 % | 32.8 % | 28.0 % | 2.00 |
| Morepen Laboratories Ltd | 2,392 Cr. | 43.7 | 70.5/33.5 | 31.3 | 21.8 | 0.45 % | 15.1 % | 11.8 % | 2.00 |
| Marksans Pharma Ltd | 7,905 Cr. | 174 | 271/156 | 21.9 | 59.3 | 0.45 % | 20.0 % | 16.8 % | 1.00 |
| Mangalam Drugs and Organics Ltd | 46.4 Cr. | 29.3 | 108/22.7 | | 80.5 | 0.00 % | 8.03 % | 4.71 % | 10.0 |
| Lyka Labs Ltd | 227 Cr. | 63.6 | 129/56.6 | | 28.3 | 0.00 % | 9.91 % | 9.31 % | 10.0 |
| Lupin Ltd | 1,05,636 Cr. | 2,311 | 2,335/1,774 | 21.3 | 430 | 0.52 % | 21.3 % | 20.6 % | 2.00 |
| Lincoln Pharmaceuticals Ltd | 1,296 Cr. | 647 | 679/440 | 14.7 | 357 | 0.28 % | 17.3 % | 12.8 % | 10.0 |
| Laurus Labs Ltd | 59,055 Cr. | 1,094 | 1,141/517 | 73.8 | 91.1 | 0.11 % | 9.47 % | 7.75 % | 2.00 |
| Kwality Pharmaceuticals Ltd | 1,557 Cr. | 1,500 | 1,599/596 | 27.3 | 281 | 0.00 % | 18.2 % | 16.2 % | 10.0 |
| Krebs Biochemicals & Industries Ltd | 126 Cr. | 58.2 | 114/51.0 | | 74.6 | 0.00 % | 30.1 % | % | 10.0 |
| Kopran Ltd | 633 Cr. | 131 | 215/120 | 38.3 | 104 | 2.30 % | 9.75 % | 7.64 % | 10.0 |
| Kilitch Drugs (India) Ltd | 577 Cr. | 330 | 500/265 | 22.2 | 152 | 0.00 % | 15.7 % | 12.6 % | 10.0 |
| Jubilant Pharmova Ltd | 13,955 Cr. | 876 | 1,250/802 | 30.2 | 414 | 0.57 % | 9.54 % | 9.55 % | 1.00 |
| J B Chemicals & Pharmaceuticals Ltd | 33,283 Cr. | 2,073 | 2,115/1,303 | 44.2 | 243 | 0.74 % | 25.8 % | 20.1 % | 1.00 |
| Jagsonpal Pharmaceuticals Ltd | 1,122 Cr. | 168 | 302/155 | 26.3 | 37.9 | 1.48 % | 23.0 % | 18.6 % | 2.00 |
| Ipca Laboratories Ltd | 38,706 Cr. | 1,526 | 1,595/1,168 | 36.6 | 293 | 0.26 % | 14.7 % | 12.8 % | 1.00 |
| IOL Chemicals & Pharmaceuticals Ltd | 2,150 Cr. | 73.3 | 127/57.5 | 17.3 | 59.7 | 1.36 % | 8.86 % | 6.13 % | 2.00 |
| Ind-Swift Ltd | 85.4 Cr. | 15.8 | 19.9/12.0 | 10.9 | 74.2 | 0.00 % | 11.9 % | % | 2.00 |
| Ind-Swift Laboratories Ltd | 1,216 Cr. | 149 | 152/67.2 | 25.7 | 160 | 0.00 % | 0.78 % | 0.18 % | 10.0 |
| Indoco Remedies Ltd | 1,880 Cr. | 204 | 350/190 | | 106 | 0.10 % | 0.49 % | 7.02 % | 2.00 |
| Hikal Ltd | 2,435 Cr. | 198 | 457/177 | 97.4 | 96.9 | 0.69 % | 9.85 % | 7.38 % | 2.00 |
| Hester Biosciences Ltd | 1,327 Cr. | 1,560 | 2,350/1,243 | 32.4 | 397 | 0.45 % | 9.71 % | 9.18 % | 10.0 |
| Gufic BioSciences Ltd | 2,864 Cr. | 286 | 409/273 | 56.6 | 62.7 | 0.04 % | 13.2 % | 12.3 % | 1.00 |
| Granules India Ltd | 14,207 Cr. | 585 | 627/412 | 26.1 | 164 | 0.25 % | 15.1 % | 13.9 % | 1.00 |
| Glenmark Pharmaceuticals Ltd | 60,701 Cr. | 2,151 | 2,286/1,275 | 22.5 | 340 | 0.12 % | 19.4 % | 15.8 % | 1.00 |
| Glaxosmithkline Pharmaceuticals Ltd | 43,842 Cr. | 2,588 | 3,516/2,220 | 43.6 | 101 | 1.59 % | 63.2 % | 46.9 % | 10.0 |
| Gland Pharma Ltd | 30,211 Cr. | 1,834 | 2,131/1,200 | 25.5 | 610 | 0.97 % | 15.8 % | 11.6 % | 1.00 |
| FDC Ltd | 5,878 Cr. | 361 | 528/355 | 25.3 | 149 | 1.38 % | 15.9 % | 11.8 % | 1.00 |
| ERIS Lifesciences Ltd | 18,824 Cr. | 1,359 | 1,910/1,097 | 42.4 | 227 | 0.54 % | 12.2 % | 12.9 % | 1.00 |
| Dr Reddys Laboratories Ltd | 1,07,485 Cr. | 1,288 | 1,380/1,020 | 19.3 | 432 | 0.61 % | 22.7 % | 18.0 % | 1.00 |
| Dishman Carbogen Amcis Ltd | 2,773 Cr. | 177 | 322/174 | 21.0 | 406 | 0.00 % | 2.42 % | 0.32 % | 2.00 |
| Cipla Ltd | 1,08,655 Cr. | 1,345 | 1,673/1,282 | 22.8 | 408 | 0.97 % | 22.7 % | 17.8 % | 2.00 |
| Caplin Point Laboratories Ltd | 13,027 Cr. | 1,714 | 2,397/1,551 | 21.2 | 416 | 0.35 % | 25.8 % | 22.7 % | 2.00 |
| Brooks Laboratories Ltd | 200 Cr. | 67.8 | 166/58.4 | 9.23 | 39.3 | 0.00 % | 9.93 % | 12.2 % | 10.0 |
| Bliss GVS Pharma Ltd | 2,242 Cr. | 212 | 244/105 | 20.3 | 107 | 0.23 % | 11.7 % | 8.36 % | 1.00 |
| Biofil Chemicals & Pharmaceuticals Ltd | 52.0 Cr. | 31.9 | 57.2/28.5 | 18.8 | 13.1 | 0.00 % | 4.12 % | 3.03 % | 10.0 |
| Biocon Ltd | 63,361 Cr. | 391 | 425/291 | 77.2 | 200 | 0.13 % | 6.25 % | 4.76 % | 5.00 |
| Beta Drugs Ltd | 1,047 Cr. | 1,033 | 2,000/990 | 24.3 | 219 | 0.00 % | 27.0 % | 25.9 % | 10.0 |
| Bal Pharma Ltd | 120 Cr. | 75.1 | 129/64.0 | 14.7 | 49.2 | 1.58 % | 10.1 % | 9.66 % | 10.0 |
| Bafna Pharmaceuticals Ltd | 250 Cr. | 106 | 205/69.9 | 21.8 | 38.6 | 0.00 % | 8.34 % | 7.69 % | 10.0 |
| Astrazeneca Pharma India Ltd | 21,960 Cr. | 8,784 | 10,691/6,502 | 106 | 320 | 0.36 % | 33.4 % | 23.6 % | 2.00 |
| Amrutanjan Health Care Ltd | 1,735 Cr. | 600 | 791/544 | 30.0 | 118 | 0.75 % | 22.4 % | 16.5 % | 1.00 |
| Alpa Laboratories Ltd | 138 Cr. | 65.4 | 125/61.0 | 11.7 | 92.0 | 0.00 % | 15.0 % | 11.5 % | 10.0 |
| Alkem Laboratories Ltd | 67,913 Cr. | 5,680 | 5,934/4,492 | 28.3 | 1,116 | 0.78 % | 20.4 % | 19.4 % | 2.00 |
| Alembic Pharmaceuticals Ltd | 14,099 Cr. | 717 | 1,108/716 | 21.3 | 271 | 1.54 % | 13.0 % | 11.4 % | 2.00 |
| Albert David Ltd | 412 Cr. | 721 | 959/663 | 42.8 | 690 | 0.68 % | 6.45 % | 4.39 % | 10.0 |
| Ajanta Pharma Ltd | 36,882 Cr. | 2,952 | 3,054/2,022 | 36.3 | 345 | 0.93 % | 32.4 % | 24.9 % | 2.00 |
| Advanced Enzyme Technologies Ltd | 3,313 Cr. | 296 | 367/258 | 23.0 | 133 | 1.76 % | 13.1 % | 9.54 % | 2.00 |
| Aarti Drugs Limited | 3,357 Cr. | 368 | 575/312 | 18.1 | 147 | 0.54 % | 13.5 % | 13.0 % | 10.0 |
| Industry Average | 20,671.75 Cr | 1,096.79 | | 56.27 | 201.21 | 0.37% | 16.35% | 15.16% | 6.10 |